MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference
30 Août 2023 - 2:00PM
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative
pharmacy technology company, announced today that Mark Doerr, Chief
Executive Officer, will participate in H.C. Wainwright 25th Annual
Global Investment Conference on Monday, September 11, 2023.
A recording of the event will be available at
7:00am ET on September 11, 2023 on the investor relations section
of MedAvail’s website at https://investors.medavail.com and will be
archived for 90 days.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a pharmacy technology
company, providing turnkey, in-clinic pharmacy services through its
proprietary robotic dispensing technology, the MedAvail MedCenter®.
The MedCenter is currently in use in both the primary care and
urgent care settings, as well as Federally Qualified Health Centers
(FQHCs).
MedAvail promotes patient drug adherence, resulting in better
health outcomes. Learn more at www.medavail.com.
Contacts:Investor
RelationsSteven Halper/Caroline PaulManaging Directors,
LifeSci Advisorsir@medavail.com
SOURCE MedAvail Holdings, Inc.
MedAvail (NASDAQ:MDVL)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
MedAvail (NASDAQ:MDVL)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
